Fungal meningitis deaths rise to 24, CDC reports

October 25, 2012 by Eryn Brown, Los Angeles Times

The U.S. Centers for Disease Control and Prevention reported Wednesday that a 24th person had died of fungal meningitis after receiving contaminated steroid injections. The latest victim had received an injection to treat back pain in Indiana, according to reports.

In all, the CDC said it had confirmed cases of fungal infection in 317 people, and meningitis in 54. All but two of the meningitis cases were sickened by infection with Exserohilum rostratum - a type of fungus that has been detected in unopened vials of steroids recovered from the New England Compounding Center, the Framingham, Mass.-based compounding facility that has been implicated in the outbreak. One meningitis patient was exposed to a fungus known as Aspergillus fumigatus; another, to Cladosporium (neither of which had been recognized as a cause of meningitis before now, the CDC noted Wednesday).

Around 14,000 patients may have received injections of steroids from one of the three lots implicated in the outbreak, the agency said, and 97 percent have been contacted for follow-up. In a health advisory released Tuesday, the CDC said that the greatest risk of developing meningitis occurs during the six weeks after injection. It stressed that antifungal treatment was not recommended in asymptomatic exposed patients who had not tested positive for meningitis.

Symptoms of include headache, fever, nausea, a stiff neck and sensitivity to light. The ailment is not contagious.

In the meantime, as the CDC has continued its monitoring efforts, the U.S. has been investigating the New England Compounding Center. On Tuesday, Massachusetts Gov. Deval Patrick told reporters that the state would permanently revoke the facility's pharmacy license. He also said he was assembling a special commission to consider changes to the state's pharmacy regulations, reported Boston radio station WBUR.

Explore further: US : Fungus in tainted steroids and patients match (Update 2)

Related Stories

US : Fungus in tainted steroids and patients match (Update 2)

October 18, 2012
(AP)—The fungus found in tainted steroid shots matches the one blamed in the national meningitis outbreak that has killed 20 people, federal health officials said Thursday.

US: Pharmacy's other drugs may be causing illness

October 15, 2012
Two more drugs from a specialty pharmacy linked to a meningitis outbreak are now being investigated, U.S. health officials said, as they urged doctors to contact patients who got any kind of injection from the company.

13,000 got suspect steroid shots; risk uncertain

October 8, 2012
(AP)—As many as 13,000 people received steroid shots suspected in a U.S. meningitis outbreak, health officials said Monday. But it's not clear how many are in danger.

Meningitis outbreak toll now 23 dead, 297 sickened: CDC

October 22, 2012
(HealthDay)—Twenty-three people have now died and 297 have been sickened in the nationwide meningitis outbreak apparently tied to contaminated steroid injections, U.S. health officials reported Monday.

US warns meningitis cases could rise

October 12, 2012
US authorities have managed to contact most of the thousands of people exposed to the tainted drug blamed for a meningitis outbreak that has killed 14, but warned the number of infections could rise.

US pharmacy linked to outbreak issues wide recall

October 7, 2012
(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.